Evidence & concentration worksheet · Skin & Cosmetic
GHK-Cu 50 mg
evidence.protocol.withhold-unverified.text
Evidence review
evidence.protocol.withhold-unverified.title
evidence.protocol.withhold-unverified.text
How it works
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It is studied mainly in cell, animal, cosmetic, and small topical human studies. Mechanistic findings about collagen, extracellular-matrix remodeling, or gene expression do not establish that an injected or topical commercial product produces a clinical benefit.
Route is central: topical skin exposure, application to a treated wound, and systemic injection are not equivalent. The evidence and risks for one route cannot be transferred to another.
Benefits & side effects
In a randomized study after carbon-dioxide laser resurfacing, only 13 patients completed follow-up. Objective computer and blinded assessments found no significant advantage for GHK-Cu in redness resolution, wrinkles, or overall skin quality, although patient-reported satisfaction favored the GHK-Cu regimen.[1]
A 45-person hair-loss study tested a combination of 5-aminolevulinic acid plus GHK—not GHK-Cu alone—and reported improved hair counts in some groups but no significant differences in length or thickness.[2] It cannot isolate the contribution of GHK or support injectable use. Broad claims about wound healing, hair restoration, whole-body repair, or anti-aging exceed this evidence.
Calculator
Concentration and measurement calculator
Use this only to check arithmetic from an authoritative product label, registered study protocol, or qualified clinician.
Arithmetic only — not a dose recommendation
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Enter only a concentration and target supplied by an authoritative product label, a registered study protocol, or a qualified clinician. A correct conversion does not establish that a substance, vial, route, or dose is safe or effective.
Source concentration
Source-supplied target
References
References
- Archives of Facial Plastic Surgery — Topical GHK-Cu after carbon-dioxide laser resurfacing (2006)
- Annals of Dermatology — 5-aminolevulinic acid plus GHK complex for male pattern hair loss (2016)
- U.S. FDA — Certain bulk substances that may present significant compounding safety risks (2026)
- U.S. FDA — May 2026 categories of substances nominated for 503A compounding (2026)
- U.S. FDA — Understanding the risks of compounded drugs (2026)
Other vial sizes